Even when a topic feels awkward to discuss, The Urology Group physicians encourage patients to be open and honest in order to get the best treatment.
In response to the COVID-19 health issue, we are offering telehealth as well as in-person appointments. Click to learn more.
Dr. Gary Kirsh, president of The Urology Group, was a co-author in this article, recently published in Reviews in Urology.
“Given the number of prostate biopsies performed annually in the United States and associated infectious events as a result, we sought to determine if implementation of a standardized biopsy protocol utilizing antibiotic prophylaxis based on locally derived antibiograms would result in a decrease, relative to a contemporary control population, in the incidence of infection-related complications among community-based practices.”
Paradoxical figures between rise in advance prostate cancer cases and decline in early stage are likely due to the changing landscape of screening and testing over the past 2 decades.
Although it’s still the top cause of cancer-related deaths for men over 60, prostate cancer is a disease that can often be treated if detected early. CLICK TO READ FULL ARTICLE.